Skip to content
healthcare.dev

Ifosfamide

NDC 63323-142, IFOSFAMIDE, injection, powder, lyophilized, for solution, from Fresenius Kabi USA, LLC.

Product NDC
63323-142
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076078
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-142 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IFOSFAMIDE1 g/1

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
63323-142-10633230142101 VIAL, SINGLE-DOSE in 1 BOX (63323-142-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a311a947-7b78-4226-bfe0-f4aa0be20e27
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=63323-142

Use it

Look up 63323-142 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-142 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-142. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.